14-day Premium Trial Subscription Try For FreeTry Free
Currently predicting for Mon, 6 May 2024

Trading levels for ARDS

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 0.0635 7.57 %
R2 0.0621 5.34 %
R1 0.0613 3.96 %
Current price: 0.0590
Support S1 0.0587 -0.511 %
S2 0.0579 -1.89 %
S3 0.0566 -4.12 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 0.0706 19.58 %
R2 0.0615 4.28 %
R1 0.0600 1.69 %
Current price 0.0590
Support S1 0.0588 -0.420%
S2 0.0566 -4.07%
S3 0 .

ARDS Predictions History

1 year ago
PredictionBot.Kathy predicted that ARDS for 2023-02-21 is going $0.553 (-7.75%)

1 year ago
PredictionBot.Warren predicted that ARDS for 2023-02-21 is going $0.571 (-4.84%)

1 year ago
buylowsellhigh predicted that ARDS for 2023-02-21 is going

Rank:

1 year ago
buylowsellhigh predicted that ARDS for 2023-02-17 is going

Rank:

1 year ago
buylowsellhigh predicted that ARDS for 2023-02-16 is going

Rank:

1 year ago
PredictionBot.Kathy predicted that ARDS for 2023-02-14 is going $0.652 (9.62%)

1 year ago
PredictionBot.Warren predicted that ARDS for 2023-02-14 is going $0.631 (6.03%)

1 year ago
buylowsellhigh predicted that ARDS for 2023-02-14 is going

Rank:

1 year ago
buylowsellhigh predicted that ARDS for 2023-01-09 is going

Rank:

2 years ago
JS predicted that ARDS for 2022-04-12 is going $1.42 (0.71%)

Click to get the best stock tips daily for free!

About Aridis Pharmaceuticals Inc.

Aridis Pharmaceuticals. Aridis Pharmaceuticals, Inc., a late-stage biopharmaceutical company, focuses on the discovery and development of targeted immunotherapy using fully human monoclonal antibodies (mAb) to treat life-threatening infections. Its lead product candidate is AR-301, a fully human mAb of immunoglobulin 1 (IgG1) that is in Phase III pivotal trials for the treatment of lung infections resulting from S. aureus alphatoxin. The company is also developing AR-32... ARDS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT